Gavi To Purchase $85M In Typhoid Vaccines To Immunize Children In Endemic Nations

Reuters: Vaccine alliance backs typhoid shots for poor with $85 million
“The Gavi global vaccine alliance has earmarked $85 million to help support the introduction of typhoid vaccines in poor countries where millions of children are at risk of the often deadly disease. The funds, agreed by GAVI at a meeting on Thursday, will go towards bulk-buying of new typhoid vaccines including one developed by privately held Bharat Biotech, the alliance said in a statement…” (Kelland, 11/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.